← Back to Bayer Cropscience Ltd. overview
Bayer Cropscience Ltd. — 10-Year Financials
Annual P&L, balance sheet, and key ratios from public BSE/NSE filings.
| Period | Revenue | Net Profit | EPS (₹) | Total Assets | Shareholder Equity | ROE (%) | ROCE (%) | D/E | Net Margin (%) |
|---|---|---|---|---|---|---|---|---|---|
| FY2025 | ₹5,314 cr | ₹568 cr | ₹126.38 | ₹5,246 cr | ₹2,850 cr | 19.93% | 24.51% | 0.04x | 10.69% |
| FY2024 | ₹4,892 cr | ₹741 cr | ₹164.77 | ₹4,597 cr | ₹2,849 cr | 25.99% | 33.18% | 0.02x | 15.14% |
| FY2023 | ₹4,945 cr | ₹758 cr | ₹168.71 | ₹4,679 cr | ₹2,712 cr | 27.96% | 36.34% | 0.03x | 15.33% |
| FY2022 | ₹4,577 cr | ₹645 cr | ₹143.58 | ₹4,353 cr | ₹2,524 cr | 25.56% | 32.93% | 0.03x | 14.1% |
Revenue: Total income from operations (₹ crore).
EPS: Earnings per share (₹), basic.
ROE: Net profit / average shareholder equity.
ROCE: EBIT / capital employed.
D/E: Total debt / shareholder equity.
Net Margin: Net profit as a % of revenue.
All figures sourced from public BSE/NSE filings. Ratios are pre-computed estimates and may differ from primary filings due to rounding.
Educational content — not investment adviceAll financial data is sourced from public filings and shown here for educational purposes only. EquitiesIndia.com is not a SEBI-registered Investment Adviser or Research Analyst. Nothing on this page constitutes a recommendation or solicitation to transact in any security. All data is at least 90 days old. Past performance is not indicative of future results.